newly diagnosed childhood ependymoma
Showing 1 - 25 of >10,000
Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients
Recruiting
- Medulloblastoma
- +7 more
- SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
- +2 more
-
Buffalo, New York
- +2 more
Jul 8, 2022
Malignant Glioma, Ependymoma Trial in United States (Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields))
Active, not recruiting
- Malignant Glioma
- +2 more
- Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields)
- Concurrent Optune and RT followed by Optune System alone
-
Los Angeles, California
- +8 more
Jan 17, 2023
Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of
Recruiting
- Diffuse Midline Glioma (DMG)
- +7 more
- ONC206
- Standard of Care Radiation Therapy
-
San Francisco, California
- +2 more
Sep 13, 2022
Diffuse Intrinsic Pontine Glioma, Medulloblastoma, Childhood, Recurrent Trial in Madrid (AloCELYVIR)
Recruiting
- Diffuse Intrinsic Pontine Glioma
- Medulloblastoma, Childhood, Recurrent
- AloCELYVIR
-
Madrid, SpainHospital Infantil Universitario Niño Jesús
Sep 29, 2022
Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Rochester (procedure,
Active, not recruiting
- Adult Anaplastic Astrocytoma
- +15 more
- biopsy
- +7 more
-
Rochester, MinnesotaMayo Clinic
Apr 8, 2022
Anaplastic Ependymoma, Brain Ependymoma, Cellular Ependymoma Trial in Worldwide (radiation, drug, other)
Active, not recruiting
- Anaplastic Ependymoma
- +5 more
- 3-Dimensional Conformal Radiation Therapy
- +7 more
-
Birmingham, Alabama
- +208 more
Mar 7, 2022
Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Orange, Chicago, Boston (rHSC-DIPGVax,
Recruiting
- Diffuse Intrinsic Pontine Glioma
- Diffuse Midline Glioma, H3 K27M-Mutant
- rHSC-DIPGVax
- +2 more
-
Orange, California
- +2 more
Nov 10, 2022
Childhood Favorable Prognosis Hodgkin Lymphoma, Childhood Lymphocyte Depletion Hodgkin Lymphoma, Childhood Mixed Cellularity
Completed
- Childhood Favorable Prognosis Hodgkin Lymphoma
- +5 more
- radiation therapy
- +11 more
-
Arcadia, CaliforniaChildren's Oncology Group
Mar 26, 2021
Ependymoma, Recurrent Childhood, Ependymoma Trial in Denver, Orlando (Granulocyte Macrophage Colony Stimulation Factor)
Active, not recruiting
- Ependymoma, Recurrent Childhood
- Ependymoma
- Granulocyte Macrophage Colony Stimulation Factor
-
Denver, Colorado
- +1 more
Feb 8, 2022
Down Syndrome, Acute Lymphoblastic Leukemia, Childhood Cancer Trial in Worldwide (Daunorubicin, Prednisolone, Vincristine)
Recruiting
- Down Syndrome
- +2 more
- Daunorubicin
- +9 more
-
Shatin, New Territories, Hong Kong
- +9 more
Sep 26, 2022
Glioblastoma Multiforme, Astrocytoma, Grade III, Anaplastic Ependymoma Trial in Chicago (biological, procedure, radiation)
Terminated
- Glioblastoma Multiforme
- +4 more
- Heat Shock Protein Peptide Complex-96 (HSPPC-96)
- +2 more
-
Chicago, IllinoisAnn & Robert H. Lurie Children's Hospital of Chicago
Jul 24, 2020
Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)
Active, not recruiting
- Brain and Central Nervous System Tumors
- +9 more
- DNA analysis
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 28, 2021
Radioresistance of Ependymomas in Children and Adolescents
Recruiting
- Ependymoma of Brain
- Pediatric Solid Tumor
-
Toulouse, FranceInstitut Claudius Regaud
Dec 8, 2021
The Relapses in Childhood Acute Lymphoplastic Leukemia Excluding
Completed
- Leukemia, Acute
- (no location specified)
Jul 23, 2023
Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)
Active, not recruiting
- Brain and Central Nervous System Tumors
- Induction Chemotherapy
- +3 more
-
Palo Alto, California
- +5 more
Nov 29, 2022
Leukemia, Juvenile Myelomonocytic, JMML, JCML Trial (Trametinib, Azacitidine, Fludarabine)
Not yet recruiting
- Leukemia, Juvenile Myelomonocytic
- +4 more
- Trametinib
- +3 more
- (no location specified)
May 4, 2023
Childhood Acute Promyelocytic Leukemia (M3), Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Trial in
Active, not recruiting
- Childhood Acute Promyelocytic Leukemia (M3)
- Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
- arsenic trioxide
- +7 more
-
Birmingham, Alabama
- +110 more
Mar 23, 2022
CNS Tumor, Pediatric, Chemo-induced Nausea and Vomiting, Child Solid Tumor Trial in Canada, United States (Real Acupressure
Completed
- Central Nervous System Tumor, Pediatric
- +2 more
- Real Acupressure Band
- Placebo Acupressure Band
-
Long Beach, California
- +24 more
Jul 19, 2021
Childhood Rheumatic Diseases Trial in Istanbul (Panoramic rad.)
Not yet recruiting
- Childhood Rheumatic Diseases
- Panoramic rad.
-
Istanbul, TurkeyEcem Ipek
Apr 26, 2023
Leukemia, Monocytic, Acute, Pediatric AML Trial in China (Cladribine, G-CSF, Cytarabine)
Recruiting
- Leukemia, Monocytic, Acute
- Pediatric AML
- Cladribine
- +5 more
-
Foshan, Guangdong, China
- +8 more
Mar 28, 2022
Brain Stem Glioma, Cerebral Astrocytoma, Childhood Cerebellar Anaplastic Astrocytoma Trial in Canada, United States
Active, not recruiting
- Brain Stem Glioma
- +4 more
- Bevacizumab
- +2 more
-
Birmingham, Alabama
- +136 more
Oct 15, 2022
Ovarian Reserve in Younger Newly Diagnosed Lymphomas
Active, not recruiting
- Anaplastic Large Cell Lymphoma
- +4 more
- Laboratory Biomarker Analysis
- Questionnaire Administration
-
Birmingham, Alabama
- +106 more
Jan 11, 2023
Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)
Active, not recruiting
- Anaplastic Astrocytoma
- +2 more
- Radiation Therapy
- +2 more
-
Birmingham, Alabama
- +162 more
Dec 30, 2022
Idiopathic Nephrotic Syndrome Trial in United States (Standard of Care, UrApp)
Recruiting
- Idiopathic Nephrotic Syndrome
- Standard of Care
- UrApp
-
Atlanta, Georgia
- +3 more
Jul 14, 2022